Products Solifenacin Succinate + Solifenacin Succinate + Oxybutynin Hydrochloride + Placebo
Solifenacin Succinate + Solifenacin Succinate + Oxybutynin Hydrochloride + Placebo Approved Completed 🔥 Hot Multiple Sclerosis, Neurogenic Bladder, Spinal Cord Diseases
Mar 14, 2008 → Jan 28, 2011
About Solifenacin Succinate + Solifenacin Succinate + Oxybutynin Hydrochloride + Placebo Solifenacin Succinate + Solifenacin Succinate + Oxybutynin Hydrochloride + Placebo is a approved stage product being developed by Astellas Pharma for Multiple Sclerosis. The current trial status is completed. This product is registered under clinical trial identifier NCT00629642. Target conditions include Multiple Sclerosis, Neurogenic Bladder, Spinal Cord Diseases.
Clinical Trials (1) NCT ID Phase Status Start Completion Indication NCT00629642 Approved Completed Mar 14, 2008 Jan 28, 2011 Multiple Sclerosis
Product Company Stage Hype Score Placebo + Pirtobrutinib Eli Lilly Phase 2 Abemaciclib, dexamethasone, ixazomib, pomalidomide + Enasidenib, dexamethasone, ixazomib, pomalidomide + Cobimetinib, dexamethasone, ixazomib, pomalidomide + Erdafitinib, dexamethasone, ixazomib, pomalidomide + Venetoclax, dexamethasone, ixazomib, pomalidomide + Daratumumab, dexamethasone, ixazomib, pomalidomide + Belantamab mafodotin, dexamethasone, ixazomib, pomalidomide + Selinexor, dexamethasone, ixazomib, pomalidomide Eli Lilly Phase 1/2 NEX-20A Nanexa AB Phase 1 agenT-797 MiNK Therapeutics Phase 1 Duloxetine Hydrochloride (HCI) + Placebo Eli Lilly Phase 3 Temferon Genenta Science Phase 1/2 CT-P44(Daratumumab) + Darzalex Faspro(Daratumumab) Celltrion Phase 3 CT-P53 + US-Ocrevus + EU-Ocrevus Celltrion Phase 3 CS-0777 tablets + CS-0777 tablets + CS-0777 tablets Daiichi Sankyo Phase 1 ASP7487, Velcade, Dexamethasone Astellas Pharma Phase 1/2 PHE885 Novartis Phase 2 Mirabegron + Placebo Astellas Pharma Approved Denileukin Diftitox (Ontak) Eisai Phase 1 Palonosetron Eisai Phase 2 BIW-8962 Kyowa Kirin Phase 1 KRN125(pegfilgrastim), PLR001(plerixafor) + KRN8601(filgrastim), PLR001(plerixafor) Kyowa Kirin Phase 2 KW-2478 + Bortezomib Kyowa Kirin Phase 1/2 ONO-2808 + Placebo Ono Pharmaceutical Phase 2 KW-2478 Kyowa Kirin Phase 1 ONO-4641 + ONO-4641 + ONO-4641 + ONO-4641 placebo Ono Pharmaceutical Phase 2
Other Products from Astellas Pharma